SCHEMBL22155240

SCHEMBL22155240

CN1CCOCS1(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18195192 0.78 ALDH1A1 (0.35)
SCHEMBL24263138 0.70
SCHEMBL22148457 0.70 PER2 (0.31)
SCHEMBL25926779 0.70
SCHEMBL23997227 0.70 PER2 (0.40)
SCHEMBL14118650 0.63
SCHEMBL20614479 0.62 CA12 (0.45)
SCHEMBL10001930 0.62 CA12 (0.45)
SCHEMBL1221354 0.62
SCHEMBL4622 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444300-A2 INHIBITORS OF MENIN-MLL INTERACTION Bala Therapeutics, Inc. (US) 2024-10-16 EP disclosed
EP-4198034-A1 BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2023-06-21 EP disclosed
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed
WO-2023088441-A1 KIF18A INHIBITOR 微境生物医药科技(上海)有限公司 2023-05-25 WO disclosed
US-11236069-B2 KIF18A inhibitors AMGEN INC. (US) 2022-02-01 US disclosed
US-20200239441-A1 KIF18A INHIBITORS AMGEN INC. (US) 2020-07-30 US disclosed
WO-2020132649-A1 HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS AMGEN INC. (US) 2020-06-25 WO disclosed